skinbetter science

skinbetter science is an American clinical skincare brand founded in 2016 and headquartered in Arizona. It built its business on the physician-dispensed model, selling mainly through dermatologists, plastic surgeons and medical aesthetic practices rather than ordinary retail. Since 2022 it has been owned by the French group L'Oréal [3][6], which operates it as an active brand rather than an independent company.

The brand positions itself around clinical science: products developed with dermatologists, validated in trials, and sold through medical channels. Its best-known line is AlphaRet, a retinoid-based treatment the company presents as delivering retinoid results with less irritation than conventional retinol.

⚑ Thinner sourcing. The article relies largely on the brand's own statements (T2–T3). Glowpedia is seeking independent sources.

skinbetter science was co-founded in 2016 by Jonah Shacknai, Justin Smith and Seth Rodner, whom independent coverage describes as pharmaceutical-industry professionals [4][6]. The company is headquartered in Arizona. From the outset it was built as a physician-dispensed brand, meaning its products were sold through medical practices rather than open retail, and its formulas were framed as science-led rather than aspirational.

One point of record is worth noting. Corporate and editorial sources consistently name the three founders above. A separate, uncorroborated attribution circulated naming Patricia Pao and Dr. Bruce Green alongside Shacknai; no fetched source supported it, and the packet treats Shacknai, Smith and Rodner as the founders.

The brand grew quickly within the American medical-aesthetics market. By the time of its acquisition, trade press described it as among the fastest-growing physician-dispensed skincare brands in the United States, with sales of nearly 95 million US dollars in the twelve months ended August 2022.

In September 2022, L'Oréal announced an agreement to acquire the company [3]. Some summaries have dated the L'Oréal deal to 2024; the acquisition was in fact announced on 23 September 2022 and completed later that year, while 2024 marks the brand's launch in Canada rather than its purchase [3][5]. That Canadian debut, handled through L'Oréal's Dermatological Beauty division, was its first major market outside the United States and was distributed through roughly 100 medical aesthetic clinics.

skinbetter science is owned by L'Oréal, which acquired it in 2022 and placed it within its Active Cosmetics Division [3][6]. Its existing leadership remained in place following the deal. Within the wider L'Oréal group its sister brands include Kiehl's, Lancôme, Garnier, Vichy and Maybelline.

The company frames its work as a biotechnological approach to skincare resting on three pillars: technological innovation, clinical validation focused on safety and efficacy, and ongoing partnerships with dermatologists, plastic surgeons and other healthcare professionals. In practice this means a professional, medically-oriented positioning: the brand is presented as physician-recommended and clinically validated, and its audience is largely patients of dermatology and aesthetics practices seeking professionally endorsed skincare.

The brand's signature line is AlphaRet, built on what the company calls AlphaRet Technology, a combination of a retinoid and lactic acid. L'Oréal Canada described AlphaRet as the brand's best-selling and awarded product [5]. Other well-known products include the Alto Defense Serum, an antioxidant serum the brand describes as powered by vitamins C and E plus additional antioxidants to defend against free radicals, and the sunbetter SPF range, along with eye treatments and corrective serums for concerns such as hyperpigmentation.

Consistent with its clinical positioning, the company states that its portfolio is backed by patented technologies, peer-reviewed publications and multiple clinical and toxicological studies. Products span anti-aging, moisturizing, cleansing, exfoliating and sun protection.

At acquisition, WWD characterized the brand as among the fastest-growing medical-dispensed skincare brands in the country [6], and BeautyMatter offered a similar assessment [7]. By the time of its Canadian launch, the company stated it had accumulated more than 50 international beauty awards.

The brand remains active. Acquired by L'Oréal in 2022, it operates as a live brand within the group's Dermatological Beauty and Active Cosmetics operations rather than as an independent company [3]. Its most recent notable activity is the 2024 Canadian launch, indicating an ongoing international rollout beyond its original US market [5].